A detailed history of Clal Insurance Enterprises Holdings LTD transactions in Dexcom Inc stock. As of the latest transaction made, Clal Insurance Enterprises Holdings LTD holds 13,500 shares of DXCM stock, worth $1.08 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,500
Holding current value
$1.08 Million
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $864,000 - $1.57 Million
13,500 New
13,500 $905,000
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $160,065 - $214,770
-1,500 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$80.99 - $107.93 $121,484 - $161,895
1,500 New
1,500 $641,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Clal Insurance Enterprises Holdings LTD Portfolio

Follow Clal Insurance Enterprises Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clal Insurance Enterprises Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Clal Insurance Enterprises Holdings LTD with notifications on news.